NRAS and cancer: In our previous study (25, 27), we demonstrated that dual inhibition of ACK1 and GCK by multi-targeted kinase, GNF-7 and its derivatives, displays strong capabilities of cellular inhibition on both Ba/F3 cells transformed with NRAS-G12D and OCI-AML3, a human cancer cell harboring NRAS-Q61L mutation.